Audio
Evaluating the Malignant Potential of Nevus Spilus
In this edition of the "Peer to Peer" audiocast series, Dr. Vincent DeLeo speaks with Dr. Robert Brodell about the malignant potential of nevus...
Article
ACIP approves change to hepatitis B vaccination guidelines
Minor change in language for hepatitis B birth dose was unanimously approved.
Article
Computed tomography angiography after NCCT delays thrombectomy
Performing computed tomography angiography following noncontrast computed tomography to obtain a high-resolution image of the large-vessel...
Video
VIDEO: Pre–gastric bypass antibiotics alter gut microbiome
WASHINGTON – Antibiotics given in advance of gastric bypass surgery preferentially alter the microbiome, nudging it toward a more “lean”...
Article
FBN-1 Overexpression Linked to Testicular Tumor Development
Fibrillin-1 could be a factor in germ cell neoplasia in situ development, according to new research.
Article
ACOS under-recognized, under-treated
Exacerbations in bronchodilator-responsive asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS) were more frequent and severe than...
Article
Odanacatib reduced fractures but upped stroke risk
Based on an independent analysis and verification of the risk for stroke, the drug’s sponsor, Merck, has withdrawn odanacatib from review by the...
Article
Abnormal Wound Healing Related to High-Dose Systemic Corticosteroid Therapy in a Patient With Ehlers-Danlos Syndrome Benign Hypermobility Type
The adverse impact of chronic corticosteroid therapy on wound healing has been well characterized, as has abnormal wound healing known to occur in...
Article
Low serum AMH predicted miscarriage after IVF
Low serum levels of anti-Müllerian hormone predicted miscarriage after in vitro fertilization and embryo transfer, according to a single-center...
Article
Tildrakizumab for psoriasis scores high marks in phase III
VIENNA – Tildrakizumab, a novel biologic for moderate to severe psoriasis, showed favorable efficacy and safety outcomes in two pivotal phase III...